Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders

Author： D'Amato M.   Rovati L.C.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.7, 1997-07, pp. : 819-836

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Caerulein May Potentiate Morphine-induced Antinociception by Cholecystokinin-A and/or Cholecystokinin-B Receptor Mechanisms

By Rezayat M.   Oreizi S.   Zarrindast M.R.  

General Pharmacology, Vol. 28, Iss. 2, 1997-02 ,pp. : 337-340

Elsevier

Access to resources Recommend Favorite

Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders

By Mally J.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 311-320

Adis International

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E.   Noll G.   Lüscher T.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Mixed results with endothelin receptor antagonists in cardiovascular disorders

By  

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function

By Varga G.   Kordas K.   Burghardt B.   Gacsalyi I.   Szenasi G.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 315-323

Elsevier

Access to resources Recommend Favorite